NRx Pharma board member Janet Rehnquist resigns; JGS Holdings gets board designation right

NRX Pharmaceuticals, Inc.

Janet Rehnquist resigned from the Board effective January 7, 2025; no disagreement with Company.
Term sheet with JGS Holdings LLC (Sauer Nunes) grants right to designate a Board member.
Management currently considering nominees from JGS Holdings for appointment to the Board.

item 5.02 item 8.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Janet Rehnquist

member of the Board of Directors

NRXP · NRX Pharmaceuticals, Inc.

Effective: 2025-01-07
Filed: January 14, 2025, 6:59 PM ET

On January 7, 2025, Janet Rehnquist resigned as a member of the Board of Directors (“ Board ”) of NRx Pharmaceuticals, Inc. (the “ Company ”), effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Janet Rehnquist resigned as member of the Board of Directors at NRX Pharmaceuticals, Inc..

Action: resigned
Role: member of the Board of Directors

Exact text from the filing

On January 7, 2025, Janet Rehnquist resigned as a member of the Board of Directors (“ Board ”) of NRx Pharmaceuticals, Inc. (the “ Company ”), effective immediately.

View on SEC.gov

NRX Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-25-001113

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.